Since 1986, when MDA-funded researchers identified the gene that, when flawed, leads to Duchenne muscular dystrophy (DMD), scientists have been actively pursuing treatments and cures. In the past 12 months, MDA has awarded research grants to the following individuals who are building on the strong foundation of previous research and discovery to better understand — and someday cure — the disease.
Dean Burkin was awarded an MDA research grant to test the effects of an existing FDA-approved drug on the function of heart and skeletal muscle in a mouse model of DMD.
Feng Yue, of Purdue University was awarded an MDA development grant totaling more than $175,000 over three years to evaluate the therapeutic potential of a protein called PTEN in DMD.
Dr. Mattia Quattrocelli of Northwestern University was awarded an MDA grant to study the effects of glucocorticoids in DMD.
Tejvir Khurana, a professor at the University of Pennsylvania was awarded an MDA grant to test a therapeutic strategy for DMD.
Postdoctoral associate James Novak was awarded an MDA grant totaling $180,000 to study exon skipping drugs in DMD.
Learn more about MDA’s Research Grants.